Ignite Creation Date:
2025-12-25 @ 12:09 AM
Ignite Modification Date:
2026-01-28 @ 6:13 PM
Study NCT ID:
NCT01676558
Status:
UNKNOWN
Last Update Posted:
2012-11-14
First Post:
2012-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Sponsor:
Organization: